In recent years, with the development of research and the development of next-generation sequencing (NGS) technology, some studies have determined other non-driver mutations in MPN, such as TET2, ASXL1, DNMT3A, TP53, EZH2, IDH1, and IDH2. This evidence concerns the gene TET2 and myeloproliferative neoplasm.